Hosted on MSN1mon
Turning point in drug prices is around the corner, says Cantor Fitzgerald's Louise ChenLouise Chen, Cantor Fitzgerald senior analyst, joins ‘Squawk Box’ to discuss Novo Nordisk's CEO on Capitol Hill, when drug prices could start to come down, and more. Supreme Court Hands ...
A day after Novo Nordisk (NVO) CEO Lars Fruergaard Jørgensen was grilled by a U.S. Senate committee, Cantor Fitzgerald ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hookipa Pharma (HOOK – Research Report) ...
In a report released yesterday, Louise Chen from Cantor Fitzgerald maintained a Buy rating on AbbVie (ABBV – Research Report), with a ...
Louise Chen is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future ...
Thank you for standing by. Welcome to the Merck & Co. Q3 sales and earnings conference call. (Operator Instructions) This call is being recorded. If you have any objections, you may disconnect at this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback